Yaobin Ouyang

1.5k total citations · 1 hit paper
39 papers, 1.0k citations indexed

About

Yaobin Ouyang is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yaobin Ouyang has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 21 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yaobin Ouyang's work include Helicobacter pylori-related gastroenterology studies (25 papers), Gastric Cancer Management and Outcomes (10 papers) and Gut microbiota and health (8 papers). Yaobin Ouyang is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (25 papers), Gastric Cancer Management and Outcomes (10 papers) and Gut microbiota and health (8 papers). Yaobin Ouyang collaborates with scholars based in China, United States and Hong Kong. Yaobin Ouyang's co-authors include Nonghua Lü, Nianshuang Li, Chao Peng, Cong He, Yi Hu, Yin Zhu, Chuan Xie, Zhenhua Zhu, Xinbo Xu and Xu Shu and has published in prestigious journals such as Nature, Oncogene and Applied Microbiology and Biotechnology.

In The Last Decade

Yaobin Ouyang

37 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bilibili, TikTok, and YouTube as sources of information on gastric cancer: assessment and analysis of the content and quality

2024 34 citations Menghui Wang, Nan Yao et al. BMC Public Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yaobin Ouyang China	20	585	379	233	162	161	39	1.0k
Juan Carlos Bravo Colombia	17	780 1.3×	195 0.5×	404 1.7×	208 1.3×	121 0.8×	52	1.1k
Monika Sitarz Poland	11	531 0.9×	458 1.2×	506 2.2×	290 1.8×	75 0.5×	22	1.4k
Daisuke Shirasaka Japan	18	789 1.3×	212 0.6×	250 1.1×	174 1.1×	229 1.4×	64	1.2k
Izumi Inoue Japan	19	626 1.1×	168 0.4×	542 2.3×	133 0.8×	148 0.9×	60	1.2k
Naoto Kurihara Japan	17	288 0.5×	347 0.9×	209 0.9×	262 1.6×	120 0.7×	46	1.1k
Taku Tsukui Japan	19	436 0.7×	248 0.7×	154 0.7×	253 1.6×	205 1.3×	55	1.2k
Maria Luísa Cordeiro Santos Brazil	13	303 0.5×	140 0.4×	112 0.5×	131 0.8×	70 0.4×	24	733
Manuel B. Braga Neto United States	19	298 0.5×	145 0.4×	108 0.5×	91 0.6×	97 0.6×	52	718
Chi‐Tan Hu Taiwan	18	192 0.3×	303 0.8×	83 0.4×	79 0.5×	81 0.5×	48	823

Countries citing papers authored by Yaobin Ouyang

Since Specialization

Citations

This map shows the geographic impact of Yaobin Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaobin Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaobin Ouyang more than expected).

Fields of papers citing papers by Yaobin Ouyang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaobin Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaobin Ouyang. The network helps show where Yaobin Ouyang may publish in the future.

Co-authorship network of co-authors of Yaobin Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Yaobin Ouyang. A scholar is included among the top collaborators of Yaobin Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaobin Ouyang. Yaobin Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yanan, Nianshuang Li, Ziwen He, et al.. (2025). Helicobacter pylori activates DOPEY1 to promote p53 degradation through the USP7/TRIP12 axis in gastric tumorigenesis. Oncogene. 44(18). 1245–1258. 2 indexed citations

Kloeber, Jake A., Bin Chen, Guangchao Sun, et al.. (2025). KCTD10 is a sensor for co-directional transcription–replication conflicts. Nature. 648(8092). 210–219.

Peng, Chao, Xinbo Xu, Yaobin Ouyang, et al.. (2024). Spatial Variation of the Gastrointestinal Microbiota in Response to Long‐Term Administration of Vonoprazan in Mice With High Risk of Gastric Cancer. Helicobacter. 29(4). e13117–e13117. 2 indexed citations

Wang, Menghui, Nan Yao, Jianming Wang, et al.. (2024). Bilibili, TikTok, and YouTube as sources of information on gastric cancer: assessment and analysis of the content and quality. BMC Public Health. 24(1). 57–57. 34 indexed citations breakdown →

Ouyang, Yaobin, et al.. (2023). Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023. Helicobacter. 28(5). e13012–e13012. 5 indexed citations

Hu, Yi, Cong He, Yaobin Ouyang, et al.. (2023). Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study. Frontiers in Immunology. 13. 1049908–1049908. 27 indexed citations

Hu, Yi, Yaobin Ouyang, Cong He, et al.. (2022). Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan‐amoxicillin dual therapy for Helicobacter pylori eradication. Helicobacter. 27(5). e12923–e12923. 8 indexed citations

He, Cong, Chao Peng, Xinbo Xu, et al.. (2022). Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota. Helicobacter. 27(4). e12898–e12898. 36 indexed citations

Ouyang, Yaobin, et al.. (2022). Amoxicillin‐vonoprazan dual therapy forHelicobacter pylorieradication: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 37(9). 1666–1672. 37 indexed citations

10.

Hu, Yi, Yaobin Ouyang, Cong He, et al.. (2022). Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study. Helicobacter. 27(4). e12896–e12896. 42 indexed citations

11.

He, Cong, Chao Peng, Huan Wang, et al.. (2022). Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis. Gastric Cancer. 25(5). 837–849. 31 indexed citations

12.

Xu, Xinbo, Xidong Wu, Yaobin Ouyang, et al.. (2022). A positive feedback loop of the TAZ/β-catenin axis promotes Helicobacter pylori-associated gastric carcinogenesis. Frontiers in Microbiology. 13. 1065462–1065462. 5 indexed citations

13.

Zuo, Wei, Hui Yang, Nianshuang Li, et al.. (2022). Helicobacter pylori infection activates Wnt/β-catenin pathway to promote the occurrence of gastritis by upregulating ASCL1 and AQP5. Cell Death Discovery. 8(1). 257–257. 20 indexed citations

14.

Ouyang, Yaobin, Wenjing Zhang, Chen He, et al.. (2022). Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. Frontiers in Medicine. 9. 844915–844915. 14 indexed citations

15.

Ouyang, Yaobin, Wenjing Zhang, Yao Wang, et al.. (2021). Effect of Helicobacter pylori eradication on hyperplastic gastric polyps: A systematic review and meta‐analysis. Helicobacter. 26(5). e12838–e12838. 9 indexed citations

16.

Ouyang, Yaobin, Zhihao Zhu, Li Huang, et al.. (2021). Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020. Helicobacter. 26(5). e12835–e12835. 6 indexed citations

17.

Hu, Yi, Yaobin Ouyang, Yin Zhu, & Nonghua Lü. (2021). Reverse hybrid therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis. Helicobacter. 26(2). e12784–e12784. 5 indexed citations

18.

Peng, Chao, Xinbo Xu, Nianshuang Li, et al.. (2021). Helicobacter pylori infection worsens impaired glucose regulation in high-fat diet mice in association with an altered gut microbiome and metabolome. Applied Microbiology and Biotechnology. 105(5). 2081–2095. 26 indexed citations

19.

Xie, Chuan, Nianshuang Li, Huan Wang, et al.. (2020). Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to H. pylori infection. Gut Microbes. 11(6). 1567–1589. 53 indexed citations

20.

He, Cong, Chao Peng, Huan Wang, et al.. (2019). The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults. Helicobacter. 24(4). e12590–e12590. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact